Detalhe da pesquisa
1.
Efficacy and safety of bimekizumab in patients with moderate-to-severe hidradenitis suppurativa (BE HEARD I and BE HEARD II): two 48-week, randomised, double-blind, placebo-controlled, multicentre phase 3 trials.
Lancet
; 403(10443): 2504-2519, 2024 Jun 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38795716
2.
Hidradenitis suppurativa: new insights into disease mechanisms and an evolving treatment landscape.
Br J Dermatol
; 190(2): 149-162, 2024 Jan 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-37715694
3.
Proof-of-concept study exploring the effect of spesolimab in patients with moderate-to-severe hidradenitis suppurativa: A randomized, double-blind, placebo-controlled clinical trial.
Br J Dermatol
; 2024 Apr 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38576350
4.
Global consensus process to establish a core dataset for hidradenitis suppurativa registries.
Br J Dermatol
; 190(4): 510-518, 2024 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37976235
5.
Needle-free electronically-controlled jet injector treatment with bleomycin and lidocaine is effective and well-tolerated in patients with recalcitrant keloids.
Lasers Surg Med
; 56(1): 45-53, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37933762
6.
A multimodal, comprehensive characterization of a cutaneous wound model in healthy volunteers.
Exp Dermatol
; 32(7): 1028-1041, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37051698
7.
Guselkumab for hidradenitis suppurativa: a phase II, open-label, mode-of-action study.
Br J Dermatol
; 188(5): 601-609, 2023 04 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36811949
8.
Adalimumab in conjunction with surgery compared with adalimumab monotherapy for hidradenitis suppurativa: A Randomized Controlled Trial in a real-world setting.
J Am Acad Dermatol
; 89(4): 677-684, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37116615
9.
Clindamycin-Benzoyl Peroxide Gel Compared with Clindamycin Lotion for Hidradenitis Suppurativa: A Randomized Controlled Assessor-Blinded Intra-Patient Pilot Study.
Dermatology
; 239(4): 670-674, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37080176
10.
Validity and Reliability of Two Digital Wound Measurement Tools after Surgery in Patients with Hidradenitis Suppurativa.
Dermatology
; 239(1): 99-108, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-35998557
11.
External Validation of the IHS4-55 in a European Antibiotic-Treated Hidradenitis Suppurativa Cohort.
Dermatology
; 239(3): 362-367, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36630943
12.
Development and validation of IHS4-55, an IHS4 dichotomous outcome to assess treatment effect for hidradenitis suppurativa.
J Eur Acad Dermatol Venereol
; 37(2): 395-401, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36184889
13.
Adalimumab combined with methotrexate versus adalimumab monotherapy in psoriasis: Three-year follow-up data of a single-blind randomized controlled trial.
J Eur Acad Dermatol Venereol
; 37(9): 1815-1824, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37014287
14.
Needle-free electronically controlled jet injection with corticosteroids in recalcitrant keloid scars: a retrospective study and patient survey.
Lasers Med Sci
; 38(1): 250, 2023 Nov 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37917309
15.
Insights into hidradenitis suppurativa.
J Allergy Clin Immunol
; 149(4): 1150-1161, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35189127
16.
Registries, multicentre and genome-wide association studies in hidradenitis suppurativa.
Exp Dermatol
; 31 Suppl 1: 22-28, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35582836
17.
IL-17A is a pertinent therapeutic target for moderate-to-severe hidradenitis suppurativa: Combined results from a pre-clinical and phase II proof-of-concept study.
Exp Dermatol
; 31(10): 1522-1532, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35638561
18.
New insights in hidradenitis suppurativa from a population-based Dutch cohort: prevalence, smoking behaviour, socioeconomic status and comorbidities.
Br J Dermatol
; 186(5): 814-822, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34921556
19.
Factors associated with treatment satisfaction in patients with hidradenitis suppurativa: results from the Global VOICE project.
Br J Dermatol
; 187(6): 927-935, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36056741
20.
Topical antimicrobial peptide omiganan recovers cutaneous dysbiosis but does not improve clinical symptoms in patients with mild to moderate atopic dermatitis in a phase 2 randomized controlled trial.
J Am Acad Dermatol
; 86(4): 854-862, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33010325